Similar articles

• [Effect of different therapeutic schedules of antacids on the pH of gastric content, varying dosage and time of administration, in patients with duodenal ulcer].

  Ribeiro TC, Coelho LG, Avelar CD, Castro LP. Ribeiro TC, et al. AMB Rev Assoc Med Bras. 1984 Jul-Aug;30(7-8):144-6. AMB Rev Assoc Med Bras. 1984. PMID: 6395220 Clinical Trial. Portuguese. No abstract available.
• Antacids and anticholinergics in the treatment of duodenal ulcer.

  Walan A. Walan A. Clin Gastroenterol. 1984 May;13(2):473-99. Clin Gastroenterol. 1984. PMID: 6086186 Review.
• [Efficacy of a new antacid in duodenal ulcer].

  Panijel M. Panijel M. Med Welt. 1982 Mar 19;33(11):415-7. Med Welt. 1982. PMID: 7045563 Clinical Trial. German. No abstract available.
• Peptic ulcer disease: review and update.

  Levine D. Levine D. R I Med J (1976). 1982 Aug;65(8):315-23. R I Med J (1976). 1982. PMID: 6755630 Review. No abstract available.
• [Comparison of 2 antacids with different acid binding capacity in low dosage in the treatment of duodenal ulcer].

  Hüttemann W. Hüttemann W. Med Klin (Munich). 1988 Jan 15;83(1):12-6. Med Klin (Munich). 1988. PMID: 3280957 Clinical Trial. German. No abstract available.